Literature DB >> 33174075

Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis.

Saeid Bagheri-Mohammadi1,2,3.   

Abstract

Microglia as resident cells of the brain can regulate neural development and maintenance of neuronal networks. Any types of pathologic events or changes in brain homeostasis are involved in the activation of microglia. This activation depends on the context, type of the stressor, or pathology. Due to the release of a plethora of substances such as chemokines, cytokines, and growth factors, microglia able to influence the pathologic outcome. In Alzheimer's disease (AD) condition, the deposition of amyloid-β (Aβ) result in provokes the phenotypic activation of microglia and their elaboration of pro-inflammatory molecules. New investigations reveal that cellular therapy with stem cells might have therapeutic effects in preventing the pathogenesis of AD. Although many strategies have focused on the use of stem cells to regenerate damaged neurons, new researches have demonstrated the immune-regulatory feature of stem cells which can modulate the activity state of microglia as well as mediates neuroinflammation. Hence, understanding the molecular mechanisms involved in the brain homeostasis by the protective features of mesenchymal stem cells (MSCs) could lead to remedial treatment for AD.

Entities:  

Keywords:  Alzheimer's disease; Cell therapy; Mesenchymal stem cells; Microglia; Stem cells

Mesh:

Year:  2020        PMID: 33174075     DOI: 10.1007/s11064-020-03162-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  60 in total

Review 1.  The role of microglia in the healthy brain.

Authors:  Marie-Ève Tremblay; Beth Stevens; Amanda Sierra; Hiroaki Wake; Alain Bessis; Axel Nimmerjahn
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Neuroinflammatory responses in Alzheimer's disease.

Authors:  Cira Dansokho; Michael Thomas Heneka
Journal:  J Neural Transm (Vienna)       Date:  2017-12-22       Impact factor: 3.575

3.  Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.

Authors:  Saeid Bagheri-Mohammadi; Behrang Alani; Mohammad Karimian; Rana Moradian-Tehrani; Mahdi Noureddini
Journal:  Mol Biol Rep       Date:  2019-05-23       Impact factor: 2.316

Review 4.  Stem cell therapies for Alzheimer's disease: is it time?

Authors:  Sheng-Min Wang; Chang-Uk Lee; Hyun Kook Lim
Journal:  Curr Opin Psychiatry       Date:  2019-03       Impact factor: 4.741

5.  [Diagnostic importance of the manganese content of cattle hair. 3. Cleaning the hair, a prerequisite for the determination of physiological manganese levels].

Authors:  E Mehnert; R Hudec
Journal:  Arch Exp Veterinarmed       Date:  1984-01

Review 6.  Alzheimer's disease: Abeta, tau and synaptic dysfunction.

Authors:  Frank M LaFerla; Salvatore Oddo
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

Review 7.  Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.

Authors:  Saeid Bagheri-Mohammadi; Mohammad Karimian; Behrang Alani; Javad Verdi; Rana Moradian Tehrani; Mahdi Noureddini
Journal:  J Cell Physiol       Date:  2018-08-26       Impact factor: 6.384

Review 8.  Microglia: new roles for the synaptic stripper.

Authors:  Helmut Kettenmann; Frank Kirchhoff; Alexei Verkhratsky
Journal:  Neuron       Date:  2013-01-09       Impact factor: 17.173

Review 9.  Microglia in Alzheimer's disease.

Authors:  David V Hansen; Jesse E Hanson; Morgan Sheng
Journal:  J Cell Biol       Date:  2017-12-01       Impact factor: 10.539

10.  Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation.

Authors:  Ramon Velazquez; Eric Ferreira; Sara Knowles; Chaya Fux; Alexis Rodin; Wendy Winslow; Salvatore Oddo
Journal:  Aging Cell       Date:  2019-09-27       Impact factor: 9.304

View more
  5 in total

1.  Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer's Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation.

Authors:  Saeid Bagheri-Mohammadi; Sahar Askari; Behrang Alani; Maryam Moosavi; Rasoul Ghasemi
Journal:  J Mol Neurosci       Date:  2022-10-10       Impact factor: 2.866

2.  The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer's Pathogenesis via Specific Pathways.

Authors:  Hongle Wu; Wei Qiu; Xiaofang Zhu; Xiangfen Li; Zhongcong Xie; Isabel Carreras; Alpaslan Dedeoglu; Thomas Van Dyke; Yiping W Han; Nadeem Karimbux; Qisheng Tu; Lei Cheng; Jake Chen
Journal:  Front Aging Neurosci       Date:  2022-06-23       Impact factor: 5.702

3.  An Inhibitor of NF-κB and an Agonist of AMPK: Network Prediction and Multi-Omics Integration to Derive Signaling Pathways for Acteoside Against Alzheimer's Disease.

Authors:  Ying-Qi Li; Yi Chen; Si-Qi Jiang; Yuan-Yuan Shi; Xiao-Li Jiang; Shan-Shan Wu; Ping Zhou; Hui-Ying Wang; Ping Li; Fei Li
Journal:  Front Cell Dev Biol       Date:  2021-07-19

Review 4.  Adipose tissue-derived stem cells as a potential candidate in treatment of Alzheimer's disease: A systematic review on preclinical studies.

Authors:  Arian Madani Neishaboori; Azadeh Eshraghi; Arezou Tasouji Asl; Marjan Shariatpanahi; Mahmoud Yousefifard; Ali Gorji
Journal:  Pharmacol Res Perspect       Date:  2022-08

Review 5.  Adult Hippocampal Neurogenesis and Alzheimer's Disease: Novel Application of Mesenchymal Stem Cells and their Role in Hippocampal Neurogenesis.

Authors:  Mahdi Noureddini; Saeid Bagheri-Mohammadi
Journal:  Int J Mol Cell Med       Date:  2021-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.